Aspirin Wearing Hearts On Packages Needs CV Statement, Too – CDER
Executive Summary
In a draft US guidance, CDER encourages firms marketing OTC aspirin products with "cardiovascular-related imagery" on packaging to add a statement reminding consumers to talk to their health care providers before using aspirin for secondary prevention of CV events.
You may also be interested in...
FDA Adds 'Doctor' To CV Statement For OTC Aspirin Labeled With Hearts
In response to the US agency's guidance announced Nov. 6, the pharmaceutical firm whose name is synonymous with the ingredient aspirin, Bayer, says it is considering how it will change labeling now used for most Bayer Aspirin products that includes a statement similar to the recommended language.
FDA Adds 'Doctor' To CV Statement For OTC Aspirin Labeled With Hearts
In response to the US agency's guidance announced Nov. 6, the pharmaceutical firm whose name is synonymous with the ingredient aspirin, Bayer, says it is considering how it will change labeling now used for most Bayer Aspirin products that includes a statement similar to the recommended language.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”